DrugPatentWatch Database Preview
Mission Pharma Company Profile
What is the competitive landscape for MISSION PHARMA, and what generic alternatives to MISSION PHARMA drugs are available?
MISSION PHARMA has fifteen approved drugs.
There are two US patents protecting MISSION PHARMA drugs.
Summary for Mission Pharma
| US Patents: | 2 |
| Tradenames: | 14 |
| Ingredients: | 12 |
| NDAs: | 15 |
Drugs and US Patents for Mission Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | TINDAMAX | tinidazole | TABLET;ORAL | 021618-002 | May 17, 2004 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Mission Pharma | TINDAMAX | tinidazole | TABLET;ORAL | 021618-001 | May 17, 2004 | AB | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ||||
| Mission Pharma | CALCIBIND | cellulose sodium phosphate | POWDER;ORAL | 018757-003 | Oct 16, 1984 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mission Pharma | EQUIPIN | homatropine methylbromide | TABLET, CHEWABLE;ORAL | 086310-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Mission Pharma | PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 091396-001 | Sep 13, 2010 | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Mission Pharma | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | RX | Yes | Yes | 7,964,212 | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Mission Pharma Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2003219999 | ➤ Sign Up |
| Australia | 2003284275 | ➤ Sign Up |
| Denmark | 1490024 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2004035004 | ➤ Sign Up |
| Spain | 2380924 | ➤ Sign Up |
| Canada | 2495886 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Mission Pharma Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB98/031 | United Kingdom | ➤ Sign Up | PRODUCT NAME: 2-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL) BIPHENYL-4-YL)-METHYL)-5-(HYDROXYMETHYL)IMIDAZOLE (LOSARTAN),OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR A POTASSIUM SALT( LOSARTAN POTASSIUM) AND HYDROCHLOROTHIAZIDE,; REGISTERED: FR 338520.7 19950215; FR 558453.7 19950215; UK 00025/0338 19960412 |
| C/GB10/012 | United Kingdom | ➤ Sign Up | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| C0026 | France | ➤ Sign Up | PRODUCT NAME: RALTEGRAVIR OU L(UN DE SES SELS PHARMACEUTIQUEMENT ACCCEPTABLES EN PARTICULIER UN SEL DE POTASSIUM; REGISTRATION NO/DATE IN FRANCE: EU/1/07/436/001 DU 20071220; REGISTRATION NO/DATE AT EEC: EU/1/07/436/001 DU 20071220 |
| C0055 | France | ➤ Sign Up | PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220 |
| C/GB12/028 | United Kingdom | ➤ Sign Up | PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTERED: UK EU/1/11/734/001-011 20111209 |
| C/GB08/020 | United Kingdom | ➤ Sign Up | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/020 GRANTED TO ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. IN RESPECT OF THE PRODUCT RALTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6346 DATED 05 JANUARY 2011 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 01 JANUARY 2023. |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
